All Stories

SV Health’s latest pharma-backed dementia fund raises $269M to invest in new therapies

A dementia-focused transatlantic venture capital initiative has secured $269 million in commitments for its second fund.

May 20, 2025 - 16:10
 0
SV Health’s latest pharma-backed dementia fund raises $269M to invest in new therapies
A dementia-focused transatlantic venture capital initiative has secured $269 million in commitments for its second fund.
Read More

Tags:

Previous Article

Blueprint changes up $1.67B VantAI pact again, zeroing in on molecular glue pote...

Next Article

Tourmaline touts cardiovascular potential of former Pfizer antibody after phase ...

Related Posts

Dynavax's feud with activist investor heats up ahead of annual meeting

Dynavax's feud with activist investor heats up ahead of...

May 12, 2025  0

RA Capital’s biotech incubator lays off staffers: Stat

RA Capital’s biotech incubator lays off staffers: Stat

May 14, 2025  0

Fierce Biotech Layoff Tracker 2025: Prime trims team by 25%; Schrödinger lays off 60 staffers

Fierce Biotech Layoff Tracker 2025: Prime trims team by...

May 20, 2025  0